EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical and Neurodevelopmental Characteristics of Paralogous Gain‐of‐Function Variants at GRIA2 p.Gly792 and GRIA3 p.Gly803

Emilie Sjøstrøm, Dorota Studniarczyk, Xinyao Dou iD, Rebekka S Dahl, Vincent Cruz, Heng Wang, Sandra Mercier, Wallid Deb, Thomas Besnard, Jennifer Friedman iD, Miriam Essid iD, Sana Karoui und 13 weitere

Clinical Genetics · 2025

DOI: 10.1111/cge.14770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Emilie Sjøstrøm und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Danish Epilepsy Center, Dianalund, Denmark. Hauptthemen laut MEDLINE: Receptors, AMPA, Neurodevelopmental Disorders, Gain of Function Mutation, Genetic Predisposition to Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CureGRIN Foundation, MRC Programme, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GRIA‐related disorders arise from disease‐causing variants in GRIA1 , GRIA2 , GRIA3 , or GRIA4 that encode α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA)‐type glutamate receptors (AMPARs). Rare monoallelic GRIA1–4 variants affecting AMPAR function can potentially lead to neurodevelopmental disorders. The impact on AMPAR function may manifest as either gain‐of‐function (GOF) or loss‐of‐function (LOF). We recruited nine unrelated patients with either known disease‐causing GOF variants in GRIA3 at position p.Gly803 or variants at the paralogous position in GRIA2 (p.Gly792). Specifically, five patients carried a de novo GRIA3 variant (p.Gly803Glu or p.Gly803Val), one carried a maternally inherited GRIA3 variant (p.Gly803Ala) and three carried de novo GRIA2 variants (p.Gly792Arg, p.Gly792Val, or p.Gly792Glu) which we demonstrate are also GOF. Recurrent symptoms included developmental delay affecting both motor skills and language abilities; cognitive impairment; behavioral and psychiatric comorbidities; hypertonia, cerebral palsy, non‐epileptic myoclonus, and treatment‐resistant epilepsy. We also provide insights into social skills, levels of autonomy, living arrangements, and educational attainment. We compared the clinical features associated with the two paralogous GOF GRIA2 and GRIA3 variants. Our study elucidates the developmental aspects, cognitive abilities, seizure profiles, and behavioral challenges associated with these variants and contributes to advancing our understanding and treatment of patients affected by this rare condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AMPANeurodevelopmental DisordersGain of Function MutationGenetic Predisposition to DiseaseHumansFemaleMaleChildChild, PreschoolAdolescentAdultPhenotype

Stichwörter der Autor:innen

AMPARepilepsynatural historyneurologysyndrome

Substanzen

Receptors, AMPAglutamate receptor ionotropic, AMPA 3glutamate receptor ionotropic, AMPA 2

Autor:innen und Institutionen

  • Department of Pediatrics, Danish Epilepsy Center, Dianalund, Denmark.
  • Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.
  • Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, Dianalund, Denmark.
  • DDC Clinic for Special Needs Children, Middlefield, Ohio, USA.
  • Genetic Department, CHU Nantes, Nantes, France.
  • L'institut du Thorax, University of Nantes, CNRS, INSERM, Nantes, France.

ORCID-Profile: Xinyao Dou, Jennifer Friedman, Miriam Essid, Thouraya Benyounes

Förderung

  • CureGRIN Foundation
  • MRC Programme
  • Novo Nordisk Fonden

Zitieren

APA

Sjøstrøm, E., Studniarczyk, D., Dou, X., Dahl, R. S., Cruz, V., Wang, H., Mercier, S., Deb, W., Besnard, T., Friedman, J., Essid, M., Karoui, S., Jemaa, L. B., Benyounes, T., Lesca, G., Tonduti, D., Iascone, M., Orcesi, S., Fradin, M., …, & Bayat, A. (2025). Clinical and Neurodevelopmental Characteristics of Paralogous Gain‐of‐Function Variants at GRIA2 p.Gly792 and GRIA3 p.Gly803. Clinical Genetics. https://doi.org/10.1111/cge.14770

Vancouver

Sjøstrøm E, Studniarczyk D, Dou X, Dahl RS, Cruz V, Wang H, et al. Clinical and Neurodevelopmental Characteristics of Paralogous Gain‐of‐Function Variants at GRIA2 p.Gly792 and GRIA3 p.Gly803. Clinical Genetics. 2025. doi:10.1111/cge.14770

BibTeX
@article{Sjstrm2025,
  author = {Sjøstrøm, Emilie and Studniarczyk, Dorota and Dou, Xinyao and Dahl, Rebekka S and Cruz, Vincent and Wang, Heng and Mercier, Sandra and Deb, Wallid and Besnard, Thomas and Friedman, Jennifer and Essid, Miriam and Karoui, Sana and Jemaa, Lamia Ben and Benyounes, Thouraya and Lesca, Gaetan and Tonduti, Davide and Iascone, Maria and Orcesi, Simona and Fradin, Melanie and Dubourg, Christèle and Napuri, Silvia and Cull-Candy, Stuart G and Coombs, Ian D and Farrant, Mark and Bayat, Allan},
  title = {Clinical and Neurodevelopmental Characteristics of Paralogous Gain‐of‐Function Variants at GRIA2 p.Gly792 and GRIA3 p.Gly803},
  journal = {Clinical Genetics},
  year = {2025},
  doi = {10.1111/cge.14770}
}
Kostenlos starten →